Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs4994
rs4994
0.010 GeneticVariation BEFREE Analysis of a subgroup with a higher body mass index showed that the Trp64Arg variant increased the OR (2.63; 95% confidence interval, 1.13-6.11) for colon cancer, but not for rectal cancer, compared with the Trp64 genotype. 11706779

2001

dbSNP: rs671
rs671
0.020 GeneticVariation BEFREE However, with the rectal cancer analysis, the ORs for high alcohol consumption were greater with 487Glu/Lys genotype compared with Glu/Glu, albeit not. 12033531

2002

dbSNP: rs1801516
rs1801516
ATM
0.010 GeneticVariation BEFREE No associations were found between the IVS38-8 T/C, 5557 G/A and 5558 A/T polymorphisms and microhaplotypes in the ATM gene with respect to sporadic rectal cancer. 12827413

2004

dbSNP: rs1801673
rs1801673
ATM
0.010 GeneticVariation BEFREE No associations were found between the IVS38-8 T/C, 5557 G/A and 5558 A/T polymorphisms and microhaplotypes in the ATM gene with respect to sporadic rectal cancer. 12827413

2004

dbSNP: rs1048943
rs1048943
0.010 GeneticVariation BEFREE The authors evaluated the association of two polymorphisms in the CYP1A1 gene--the noncoding Msp I polymorphism in the 3'-untranslated region and the Ile462Val polymorphism in exon 7--with colon and rectal cancer. 15496536

2004

dbSNP: rs2227983
rs2227983
0.010 GeneticVariation BEFREE Our data suggest that the HER-1 R497K and EGFR intron 1 (CA)(n) repeat polymorphisms may be potential indicators of radiosensitivity in patients with rectal cancer treated with chemoradiation. 15701846

2005

dbSNP: rs397507444
rs397507444
0.060 GeneticVariation BEFREE This study suggests that MTHFR C677T and A1298C polymorphisms are associated with the reduced risk of colon and rectal cancers, respectively. 15829374

2005

dbSNP: rs1217691063
rs1217691063
0.050 GeneticVariation BEFREE This study suggests that MTHFR C677T and A1298C polymorphisms are associated with the reduced risk of colon and rectal cancers, respectively. 15829374

2005

dbSNP: rs1801282
rs1801282
0.020 GeneticVariation BEFREE P12A PPARgamma did not significantly interact with BMI, WHR, energy intake, and energy expenditure to alter risk of colon or rectal cancer. 15860437

2005

dbSNP: rs1805192
rs1805192
0.020 GeneticVariation BEFREE P12A PPARgamma did not significantly interact with BMI, WHR, energy intake, and energy expenditure to alter risk of colon or rectal cancer. 15860437

2005

dbSNP: rs63750114
rs63750114
0.010 GeneticVariation BEFREE We identified a MLH1 Q701X truncating mutation in the blood lymphocytes of a male who had been diagnosed with rectal cancer at the age of 35. 16521201

2006

dbSNP: rs397507444
rs397507444
0.060 GeneticVariation BEFREE We examined independent associations and interactions of folate, B vitamins, methionine, alcohol, and MTHFR polymorphisms (MTHFR C677T and A1298C) with rectal cancer. 17245555

2007

dbSNP: rs1217691063
rs1217691063
0.050 GeneticVariation BEFREE We examined independent associations and interactions of folate, B vitamins, methionine, alcohol, and MTHFR polymorphisms (MTHFR C677T and A1298C) with rectal cancer. 17245555

2007

dbSNP: rs781230344
rs781230344
0.010 GeneticVariation BEFREE Cyclin D1 gene G870A polymorphism predicts response to neoadjuvant radiotherapy and prognosis in rectal cancer. 17398034

2007

dbSNP: rs35352891
rs35352891
0.010 GeneticVariation BEFREE A 39-year-old male patient with biallelic MYH mutations (p.G272E and p.A359V) received total proctocolectomy for rectal cancer and 36 colorectal polyps. 17703316

2007

dbSNP: rs730881833
rs730881833
0.010 GeneticVariation BEFREE A 39-year-old male patient with biallelic MYH mutations (p.G272E and p.A359V) received total proctocolectomy for rectal cancer and 36 colorectal polyps. 17703316

2007

dbSNP: rs11568820
rs11568820
VDR
0.010 GeneticVariation BEFREE In this study, we examine the association of the CDX2 VDR polymorphism (rs11568820) located in the 5'-untranslated region of the gene, and VDR haplotypes, including this polymorphism, with colon and rectal cancer using data from two large case-control studies of colon (N = 1,574 cases and 1,970 controls) and rectal (n = 791 cases and 999 controls) cancer. 18086783

2007

dbSNP: rs1695
rs1695
0.010 GeneticVariation BEFREE GSTP1 Ile105Val polymorphism is a promising marker of potential haematological toxicity in elderly patients with rectal cancer receiving preoperative CRT. 18540691

2008

dbSNP: rs397507444
rs397507444
0.060 GeneticVariation BEFREE These results in the present study suggested that polymorphisms of the MTHFR C677T could influence susceptibility to colon or rectal cancer and that there was a coordinated effect between MTHFR A1298C A/A and C677T T/T genotypes among males. 18712959

2009

dbSNP: rs1217691063
rs1217691063
0.050 GeneticVariation BEFREE These results in the present study suggested that polymorphisms of the MTHFR C677T could influence susceptibility to colon or rectal cancer and that there was a coordinated effect between MTHFR A1298C A/A and C677T T/T genotypes among males. 18712959

2009

dbSNP: rs2066845
rs2066845
0.010 GeneticVariation BEFREE The goal of the current project was to analyze the frequency of selected NOD2 gene variants, including P286S, R702W, G908R, and 1007fs, in the Polish population of patients with rectal cancer. 18758419

2008

dbSNP: rs13181
rs13181
0.030 GeneticVariation BEFREE These interactions were stronger for rectal cancer cases (heterogeneity test P = 0.002 for XPD Asp312Asn and P = 0.03 for XPD Lys751Gln) and remained statistically significant after accounting for multiple testing. 19029193

2009

dbSNP: rs1799793
rs1799793
0.010 GeneticVariation BEFREE These interactions were stronger for rectal cancer cases (heterogeneity test P = 0.002 for XPD Asp312Asn and P = 0.03 for XPD Lys751Gln) and remained statistically significant after accounting for multiple testing. 19029193

2009

dbSNP: rs2227935
rs2227935
BLM
0.010 GeneticVariation BEFREE However, we detected a significant association of BLM P868L with an increased rectal cancer</span> risk (odds ratio = 1.29, 95% confidence interval 1.02-1.64 and P = 0.04), suggesting a potential cancer-site specificity. 19945966

2010

dbSNP: rs3219489
rs3219489
0.010 GeneticVariation BEFREE One SNP, rs3219489:G>C (MUTYH Q324H) seemed to confer an increased risk of rectal cancer in homozygous status (OR=1.52; CI=1.06-2.17). 20149637

2010